APP and Alzheimer disease: It is well known that the dysregulation of APP processing and metabolism is correlated to neurological disorders not limited to AD, but also Down’s Syndrome (DS), Fragile X Syndrome and Autism, in which increased sAPPα levels contributed to an excessive induction and stimulation of brain growth signals during development [134,135,136].